PRNewswire (Wed, 2-Sep 7:37 AM ET)
cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026
PRNewswire (Thu, 13-Aug 4:10 PM ET)
cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results
PRNewswire (Mon, 10-Aug 3:09 PM ET)
PRNewswire (Mon, 3-Aug 11:29 AM ET)
PRNewswire (Fri, 24-Jul 1:43 PM ET)
cbdMD's Oasis Brand Partners with Mexcor to Launch Into South Carolina
PRNewswire (Tue, 14-Jul 9:25 AM ET)
PRNewswire (Thu, 9-Jul 8:25 AM ET)
cbdMD Sets a New Safety Standard for Broad Spectrum CBD With Self-Affirmed GRAS Determination
PRNewswire (Tue, 7-Jul 8:30 AM ET)
Oasis Launches Hemp-Derived Mixer
PRNewswire (Wed, 1-Jul 9:01 AM ET)
cbdMD Welcomes White House Call for Fair Treatment of Hemp-Derived Products
PRNewswire (Thu, 25-Jun 2:15 PM ET)
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
Cbdmd trades on the AMEX stock market under the symbol YCBD.
As of September 17, 2026, YCBD stock price climbed to $0.50 with 241,002 million shares trading.
YCBD has a beta of 3.26, meaning it tends to be more sensitive to market movements. YCBD has a correlation of 0.08 to the broad based SPY ETF.
YCBD has a market cap of $5.60 million. This is considered a Sub-Micro Cap stock.
Last quarter Cbdmd reported $6 million in Revenue and -$.11 earnings per share. This fell short of revenue expectation by $-134,000 and missed earnings estimates by -$.08.
In the last 3 years, YCBD traded as high as $13.84 and as low as $.45.
The top ETF exchange traded funds that YCBD belongs to (by Net Assets): VXF.
YCBD has underperformed the market in the last year with a return of -30.3%, while the SPY ETF gained +16.7%. In the last 3 month period, YCBD fell short of the market, returning -25.1%, while SPY returned +1.9%. However, in the most recent 2 weeks YCBD has outperformed the stock market by returning 0.0%, while SPY returned -0.3%.
YCBD support price is $.45 and resistance is $.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that YCBD shares will trade within this expected range on the day.
